CompaniesClinical Genomics

Clinical Genomics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

2

As Collaborator

2

Total Enrollment

1,753

By Status

COMPLETED: 2WITHDRAWN: 1RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT03706235
NCT00843375
NCT03749083
Hover over trial bars to see details

Recent Trials

NCT03749083Collaborator
A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer
N/AWithdrawn
Started: Dec 31, 2019 · Completed: Oct 31, 2024
NCT00843375Collaborator
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
N/ARecruiting
1,200 participants
Started: Aug 7, 2019 · Completed: Mar 31, 2028
NCT03706248Lead Sponsor
Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL
N/ACompleted
65 participants
Started: Jul 28, 2018 · Completed: Jul 15, 2019
NCT03706235Lead Sponsor
Colvera for Detection of Disease Recurrence
N/ACompleted
488 participants
Started: Feb 1, 2018 · Completed: Apr 29, 2020